ARCHIVES

Phase III Five-Year Data Show Erbitux Increases Survival Of Head And Neck Cancer

This article is from The Cancer Letter archive.

Vol. 31 No. 9 | September 26, 2008

Download PDF Visit The Full Archive

Related Articles

Rogers-Kennedy Impasses Still Blocks Training Grant Bill

April 19, 1974

Foundations: Lasker Awards honor Work In Nitric Oxide, HIB Vaccine

October 4, 1996

White House Okays Committee ‘Kill’ Lists; Workshops To Plan Projects In Carcinogenesis

July 22, 1977

In Brief: Reynolds Retires “Joe Camel” advertising; Slaga Moves Lab To MC Cancer Center

July 18, 1997

DCT Board Approves More Than $25 Million In Contract Recompetitions, Two New Contracts

February 23, 1990

Emory Stops Patient Accrual After Discovering Problems In Management

June 26, 2009